Teratogens I Flashcards

1
Q

What pathogens are capable of vertical transmission?

A

viruses (echo virus, Hep A and B, measles, mumphs, rubella)
parasites
bacteria (group B strep, chlamydia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the potential effects of maternal infection on pregnancy outcomes?

A
pregnancy loss
teratogenicity
preterm birth
other pregnancy complications
transient in-utero infection
infection of the fetus/newborn
unknown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What factors affect transmission risk and fetus/newborn disease severity in MTC of viral pathogens?

A

gestational age at time of infection
circulating maternal viral load
newly acquired infections
maternal immunologic responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What factors influence transmission risk between mother and fetus for HIV?

A
maternal viral load
breast feeding
ruptured membranes
prematurity
concomitant infections (Hep C)
acquiring HIV at the same time as pregnancy (postulated)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are adverse pregnancy outcomes associated with treatment of HIV infection with DTG?

A

pregnancy loss, prematurity, preeclampsia, gestational DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are adverse maternal effects associated with treatment of HIV infection with DTG?

A
metabolic complications (lipodystrophy, insulin resistance, osteopenia, abnormal lipid metabolism)
toxicities (hepatitis, pancreatitis, peripheral neuropathy, kidney stones)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are adverse fetal outcomes associated with treatment of HIV with DTG?

A

congenital malformations
neural tube defects
longterm health risks including HIV infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can Hep B be transmitted?

A

vertically (from mother to child)
sexually
other close (non-sexual) contact
*highly contagious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Approximately _____% of healthy adults will clear Hep B infections and develop antibodies, however in newborns exposed to Hep B, the majority ______.

A

90-95

will develop chronic infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is Hep B managed in pregnancy?

A
prenatal screening (HBsAg+ screening routine part of prenatal care)
at risk infants receive passive and active immunization at birth to prevent MTCT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference between passive and active immunization of infants for Hep B?

A

passive- Hep B IG within 12 hours of birth (100% effective in HBeAg- women but only 85% effective in HBeAg+ women)
active- Hep B vaccine within 12 hours of birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the rate of vertical transmission of Hep C?

A

10-15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

______% of children born to Hep C infected women will they themselves have chronic liver disease.

A

5-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the MTCT rates of Herpes Simplex Virus?

A

primary infection near term- 30-50%

recurrent infection near term- <1% transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can you prevent neonatal herpes?

A

preventing maternal acquisition of HSV during pregnancy

avoiding exposure to asymptomatic HSV shedding and clinically apparent herpetic lesions during delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What antepartum management is available for mothers with HSV?

A

serologic testing used for counseling women of partners with known genital herpes (seronegative women should avoid intercourse with partners in third trimester)
first episode genital herpes or frequent, severe recurrences treat with antiviral suppression (usually valacyclovir)
in women with frequent recurrences, supression reduces frequency of genital recurrences and reduces the risk of delivery via c-section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What intrapartum management is used for women with HSV?

A

C-section recommended for those with active disease (either primary or recurrent)
note this does not completely prevent vertical transmission
consider IV acyclovir as well

18
Q

What neonatal HSV management is available?

A
careful follow-up of exposed infants (routine surveillance cultures from mucosal surfaces or routine IV acyclovir if maternal infection was primary HSV)
neonatal disease (may be limited to skin and mucous membranes, systemic including CNS involvement) treated with IV acyclovir from 14-21 days depending on severity
19
Q

Primary CMV in the US complicates _____% of all pregnancies.

A

1-3

20
Q

What is the vertical risk of transmission for CMV?

A

30-40%

21
Q

What is the rate of non-primary (reactivation, re-infection) CMV during pregnancy?

A

as high as 13.5%

22
Q

What is the risk of vertical transmission for non-primary CMV?

A

0.15-2%

23
Q

CMV is the most common congenital infection occurring in _____% of neonates and is the leading cause of ______.

A

0.2-2.2%

congenital hearing loss

24
Q

What are the symptoms of primary CMV at birth in infants?

A
small for gestational age, petechiae, thrombocytopenia, jaundice, hepatosplenomegaly, microcephaly, seizures, and chorioretinitis
often fatal (survivors commonly have visual impairments, hearing loss, and mental retardation)
25
Q

_____% of infants born with primary CMV infections will be symptomatic at birth.

A

10-15

26
Q

5-10% of infants with asymptomatic primary CMV at birth will have _______.

A

varying degrees of hearing loss and/or coordination problems

27
Q

Describe strategies to prevent MTCT of CMV.

A

handwashing and effective vaccination programs

28
Q

What kinds of maternal screenings are available for CMV?

A
CMV IgM (not reliable- high false positive)
CMV Avidity testing
29
Q

How should pregnancies complicated by maternal primary CMV be evaluated?

A

US (best tool) and amnio
CMV detected in amniotic fluid by either culture or PCR (detection of CMV in amniotic fluid does not predict severity of newborn disease)

30
Q

What treatments strategies are possible for MTCT prevention of CMV?

A

immune based treatment to interrupt transmission is in currently being studied

31
Q

What is Congenital Rubella Syndrome?

A

infection of a fetus with rubella causing deafness, cataracts, heart defects, microcephaly, mental retardation, bone alterations, liver and spleen damage, and/pr fetal death or premature delivery

32
Q

What effects the severity of damage to a fetus with Congenital Rubella Syndrome?

A

gestational age at infection
defects rare after 20 weeks gestation
85% of infants affected if maternal infection occurs during first trimester

33
Q

What is the risk of vertical transmission of toxoplasmosis?

A

50% if acute toxoplasmosis occurs during pregnancy

maternal infections early in pregnancy are less likely to be vertically transmitted than infections later in gestation

34
Q

How can congenital toxoplasmosis be identified on US?

A

chorioretinitis, intracranial calcifications, hydrocephalus

35
Q

What are the long term effects of congenital toxoplasmosis infection of infants in-utero?

A

mostly asymptomatic at birth with development of learning and visual impairments later in life

36
Q

What is the risk of congenital varicella?

A

2% if infection occurs between 13-20 weeks of gestation

17-30% risk of severe infection if acute varicella in pregnant woman from 5 days before to 2 days after delivery

37
Q

What are the symptoms of congenital varicella syndrome?

A

chorioretinitis, congenital cataracts, cerebral cortical atrophy, variable degrees of limb atrophy, skin scarring, and GER

38
Q

What is the risk of MTCT of Zika virus?

A

1-10%

39
Q

What are the symptoms of congenital Zika syndrome in infants born to mothers with known Zika/

A

microcephaly, ventriculomegaly, intracerebral calcifications, ocular problems, damage to central and peripheral motor neurons

40
Q

How can mothers decrease risk of Zika?

A

don’t travel where zika is
use mosquito protection (even during pregnancy)
if returning from travels in affected areas, use condoms and wait to conceive

41
Q

What vaccinations are contraindicated in pregnancy?

A

MMR
Varicella
live attenuated influenza vaccine

42
Q

What is cocooning?

A

vaccination of mothers post-partum and other close contacts to protect infants